Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

BASF Bets on China Growth as Zhanjiang Site Targets €5 Billion in Sales by 2030

Basf (ETR:BAS) executives said the company’s new Zhanjiang Verbund site in Guangdong province has started operations successfully, positioning the German chemicals group for further growth in China while adding a major new production platform built around digitalization, feedstock flexibility and re

MarketBeat

CME Group CEO Blasts Bitcoin Perpetual Futures, Warns of ‘2007’ Risk

CME Group (NASDAQ:CME) Chairman and CEO Terry Duffy sharply criticized the Commodity Futures Trading Commission’s approval of a Bitcoin perpetual futures contract for Kalshi, saying the product does not fit his view of a futures contract and raises risks for retail investors. Speaking at an investo

MarketBeat

Chime Financial CEO Maps Growth Roadmap, $2.7B Revenue Target at Conference

Chime Financial (NASDAQ:CHYM) founder and CEO Chris Britt outlined the digital banking company’s growth strategy, product roadmap and margin targets during a presentation at the William Blair conference, emphasizing Chime’s focus on primary checking relationships and mainstream U.S. consumers. Brit

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

CG Oncology Touts Cretostimogene Data, BLA Progress in Bladder Cancer Push

CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York. Kuan said the company believes the therapy cou

MarketBeat

Certara Outlines AI Push, Cost Cuts and New Growth Engines at Jefferies Conference

Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creati

MarketBeat

Celsius Plots Energy Drink Comeback as Alani, Rockstar Deals Reshape Growth

Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth. Speaking at an investor conference, Chairman and CEO John Fieldly described the comp

MarketBeat

Petco Faces Tough Competition, But Momentum Is Building

Petco Health and Wellness is becoming a comprehensive petcare services destination capable of competing with Chewy for market share.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

CareDx Highlights 39% Q1 Growth, Naveris Oncology Push at Jefferies

CareDx (NASDAQ:CDNA) executives outlined the company’s growth strategy, first-quarter performance and pipeline priorities during a presentation at the Jefferies Healthcare Conference, emphasizing transplant diagnostics, specialty oncology and digital workflow integration. John Hanna, chief executiv

MarketBeat

Bruker Signals Growth Pivot as Semiconductor and Overseas Orders Gain Steam

Bruker (NASDAQ:BRKR) is seeing stronger order momentum across several end markets, with semiconductor metrology, non-U.S. academic and government customers, and parts of its diagnostics business helping offset continued weakness in U.S. academic funding, a company representative said at a Jefferies

MarketBeat

Black Rock Coffee Bar Targets 1,000 Stores as Loyalty Fuels Growth Plan

Black Rock Coffee Bar (NASDAQ:BRCB) executives outlined the company’s growth strategy, store economics and competitive positioning during a William Blair consumer event, emphasizing plans to sustain rapid unit expansion while leaning on customer loyalty, store-level execution and a differentiated ca

MarketBeat

Backblaze Sees AI Boom Fueling Cloud Storage Demand and Neocloud Deals

Backblaze (NASDAQ:BLZE) Chief Executive Gleb Budman said the cloud storage company is seeing a material shift in demand tied to artificial intelligence workloads, as customers seek alternatives to hyperscaler platforms and newer AI-focused cloud providers look to add storage capabilities. Speaking

MarketBeat

Blackbaud Touts AI Agents, Payments Growth and Buybacks at Baird Conference

Blackbaud (NASDAQ:BLKB) executives emphasized the company’s nonprofit software focus, artificial intelligence initiatives, payments opportunity and capital return strategy during a discussion hosted by Baird Senior Research Analyst Rob Oliver. Oliver described Blackbaud as a vertical software leade

MarketBeat

BlackLine Says AI Agents, Platform Pricing Can Reignite Revenue Growth

BlackLine (NASDAQ:BL) executives said the company is leaning on platform pricing, artificial intelligence and deeper enterprise adoption as it works to reaccelerate revenue growth, according to remarks at a William Blair conference session. Chair and CEO Owen Ryan described BlackLine as a “mission-

MarketBeat

CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?

CrowdStrike stock fell after beating earnings and raising guidance. Here's why investors may see the post-earnings selloff as a buying opportunity

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are Trading

Check out these three stocks that insiders are buying and selling, including giants in oil and AI, as well as a small gene stock seeing huge swings.

MarketBeat

BioAge Labs Eyes Key BGE-102 Readouts in Heart Risk and Diabetic Eye Disease

BioAge Labs (NASDAQ:BIOA) executives used a fireside chat at the Jefferies 2026 Global Healthcare Conference to outline the company’s plans for BGE-102, its lead NLRP3 inhibitor, with near-term readouts expected in cardiovascular risk and diabetic macular edema. The company’s chief business officer

MarketBeat

MarketBeat Week in Review – 06/01 - 06/05

Stocks sold off sharply to end the week with money moving out of technology stocks and into many of the Dow components; inflation fears are rising.

MarketBeat

Black Diamond Therapeutics Touts Silevertinib Lung Cancer Data, Eyes FDA Path

Black Diamond Therapeutics (NASDAQ:BDTX) is positioning its lead oncology drug candidate, silevertinib, as a potential treatment for non-small cell lung cancer patients with non-classical EGFR mutations, Chief Executive Officer Mark Velleca said during a Jefferies fireside chat following the company

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

BioCryst Pharmaceuticals Backs ORLADEYO Outlook as Navenibart Trial Advances

BioCryst Pharmaceuticals (NASDAQ:BCRX) CEO Charlie Gayer said the company remains on track with its commercial and development plans during a Jefferies fireside chat, highlighting continued growth expectations for hereditary angioedema drug ORLADEYO, progress for late-stage HAE candidate navenibart

MarketBeat

Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline

Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing to launch Auvelity in Alzheimer’s disease agitation this month while continuing to expand the drug’s use in major depressive disorder and advance a broad central nervous system pipeline. Speaking at a Jefferies fireside chat

MarketBeat

Axon Enterprise Touts AI, Global Markets and Counter-Drone Demand as Growth Engines

Axon Enterprise (NASDAQ:AXON) President Josh Isner said the company continues to see durable growth opportunities across public safety, international markets, enterprise customers and new artificial intelligence products, speaking during a William Blair & Company fireside chat hosted by research

MarketBeat

Avalyn Pharma Outlines Inhaled Fibrosis Push After IPO, With Pivotal Data Ahead

Avalyn Pharma (NASDAQ:AVLN) executives outlined the company’s inhaled pulmonary fibrosis strategy at the Jefferies Global Healthcare Conference, emphasizing its recent IPO, ongoing mid-stage studies and plans to position its candidates as potential backbone therapies for idiopathic pulmonary fibrosi

MarketBeat

AeroVironment Sees Drone Demand Taking Off as Switchblade, Counter-Drone Capacity Expands

AeroVironment (NASDAQ:AVAV) executives told investors at William Blair’s 46th Annual Growth Stock Conference that the company sees expanding opportunities across drones, loitering munitions and counter-drone systems, while also emphasizing ongoing capacity investments tied to programs such as Switch

MarketBeat

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands

Assembly Biosciences (NASDAQ:ASMB) is awaiting a key development plan from partner Gilead Sciences for its herpes simplex virus programs while advancing ABI-6250 into multiple liver disease indications, Chief Executive Officer Jason Okazaki said during a Jefferies biotech event. Okazaki said 2024 w

MarketBeat

Arrowhead Pharmaceuticals Lines Up SHASTA Readout as REDEMPLO Launch Gains Traction

Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives outlined upcoming clinical catalysts, early commercial trends and pipeline priorities during a Jefferies fireside chat, with Chief Medical Officer James Hamilton emphasizing that the company remains focused exclusively on siRNA therapeutics through

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.